SciDoc Publishers | Open Access | Science Journals | Media Partners

 


International Journal of Bone and Rheumatology Research (IJBRR)  /  IJBRR-2470-4520-06-101


Management Of Recurrence Benign Histiocytofibroma of Tibia: Case Report and Review Of Literature


Lahsika Mohammed*, Filali Baba, Maanouk, Abid, El Idrissi, El Ibrahimi, El Mrini

Department of Traumatology and Orthopedics, UHC Hassan II, Fez, Morocco.


*Corresponding Author

Lahsika Mohammed,
Resident, Department of Traumatology Orthopedic B4, University Hospital Hassan II Fez, Morocco.
E-mail: mlahsika@gmail.com

Received: February 17, 2021; Accepted: March 15, 2021; Published: April 23, 2021

Citation: Lahsika Mohammed, Filali Baba, Maanouk, Abid, El Idrissi, El Ibrahimi, El Mrini. Management Of Recurrence Benign Histiocytofibroma of Tibia: Case Report and Review Of Literature. Int J Bone Rheumatol Res. 2021;6(01):96-98. doi: dx.doi.org/10.19070/2470-4520-2000020

Copyright: Lahsika Mohammed©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.



Abstract

The histiocytofibroma is a mesenchymal tumor of distal cutaneous localization in most cases, bone location is unusual and especially in the long bones. She usually sits in epiphyseal or metaphyseal location. The location of the tibial shaft is very rare. Few studies have described the clinical, pathological and prognostic of bone histiocytofibroma, it is difficult to differentiate them from other rare lesions such as giant cell tumor (GCT) and non-ossifying fibroma. In this article, we will describe this very rare bone lesion and describe the clinical, therapeutic and prognostic characteristics from a case.



1.Keywords
2.Introduction
3.Observation
4.Discussion
5.Conclusion
6.References

Keywords

Bone Tumor; Benign Histiocytofibroma Of Bone; Tibia.


Introduction

Benign histiocytofibroma (BHF) is one of the most common benign tumors. It is usually located on the skin, particularly the limbs [1, 2]. Bone localization is rare, representing 1% of all benign bone tumors operated [3]. In the rare case of infringement of the long bones, the seat is especially epiphyseal and metaphyseal. The diaphysis location is exceptional.

Few studies have described the clinical, pathological and prognostic bone BHF, it is difficult to differentiate them from other rare lesions such as giant cell tumor (GCT) and non-ossifying fibroma.

The purpose of this article is to describe this rare bone injury and to summarize the clinical, therapeutic and prognostic from a case.


Observation

This is an 18-year-old patient, with no history, presenting for 8 years (at the age of 12) a palpable swelling of progressive on set with mechanical pain in the right leg.

The patient was operated on for excisional biopsy with an anatomopathological result in favor of a benign histiocytofibroma.

The development was marked 1 year ago by the onset of swelling and pain at the same site.

Clinical examination revealed firm swelling, poorly defined, tender to palpation and fixed relative to the deep plane at the anterior tibial ridge 2cm below the anterior tibial tuberosity. It measured 4 × 2 cm. There was no vascular or nervous deficit, the regional lymph nodes were free, and the knee and ankle joints were free. The standard radiograph showed a well-defined lacunar image, mid-diaphyseal of the tibia, with sclerotic marginal sclerosis without periosteal reaction making stage Ia according to the LODWICK classification [4]. (Fig. 1).


Figure 1. Standard radiograph showed lacunar image, mid-diaphyseal of the tibia, with sclerotic marginal sclerosis without periosteal reaction making stage Ia according to the LODWICK classification.


MRI revealed an osteolytic lesion, spindle-shaped with lobulated contours, hyper T1 and hyper T2 very restrictive in diffusion and quite strongly enhanced at the periphery, blowing the cortex with rupture in places, without periosteal reaction. No infiltration of the soft parts opposite. This lesion measured 30 × 10 × 8 mm (Fig. 2).


Figure 2. MRI revealed an osteolytic lesion, measured 30 × 10 × 8 mm , hyper T1 and hyper T2, blowing the cortex with rupture in places, without periosteal reaction. No infiltration of the soft parts opposite.


Laboratory results including a complete blood count, routine biochemical studies, serum calcium, phosphorus and parathyroid hormone assays were unremarkable.

Macroscopically, the tumor blew out the cortex without any foci of rupture. The solid component was yellowish shiny in appearance.

A large resection of the tumor was performed. Reconstruction was carried out with a corticosteroid-cancellous graft from the ipsilateral anterior iliac crest (Figure 3).


Figure 3. a. The tumor blew out the cortex without any foci of rupture. The solid component was yellowish shiny in appearance.
b. Large resection of the tumor was performed.
c. Reconstruction was carried out with a corticosteroid-cancellous graft from the ipsilateral anterior iliac crest.


Histological examination of the excisional piece revealed a benign fibroblastic tumor proliferation, the morphological appearance of which is compatible with a benign histiocytofibroma. There was no sign of malignancy, and the excisional margins were free from tumor proliferation.

The limb was immobilized by a knee brace for six weeks, then knee and ankle rehabilitation was scheduled afterwards.

Radiographic controls at 3, 6 and 12 months showed progressive integration of the graft. No sign of local recurrence, displacement or disassembly of the equipment was noted.


Discussion

BHF accounts for about 1% of all benign bone tumors treated with surgery [5]. HBF of bone presents a diagnostic challenge because this lesion shares clinical symptoms, radiological features and histological features common with other benign lesions such as non-ossifying fibroma, giant cell tumor, fibrous dysplasia, aneurysmal bone cyst, osteoblastoma and eosinophilic granuloma.

Clinically, BHF is more commonly present in young adults between the ages of 20 and 40 and has no gender predilection. This tumor occurs more often in long bones than in flat bones, but the tibia is rarely involved.

Pain is the most frequent master of symptoms [4, 6, 7]. Nonossifying fibromas are generally asymptomatic, except in the event of a fracture and it is sometimes difficult to distinguish this tumor from other rare tumors presenting with multi-compartmental osteolytic lesions, in particular the TCGs. Few works have described the radiographic characteristics of the HBFB of the tibial shaft [8].

BHF appears on radiography as a well-defined, osteolytic, uni or multilocular lesion, with a sclerotic border. It can be centered or eccentric. Cortical extension may be present, especially in flat bones. A periosteal reaction and extension to adjacent tissues are rarely described [9, 10]. Soft tissue extension is not present. Rarely, the lesion is less well defined, with fuzzy boundaries suggesting a malignant tumor [7].

Histologically, BHF contains varying amounts of spindle-shaped fibrohistiocytic cells, multinucleated giant cells and foam cells [7]. Immunohistochemically, the most prevalent reactivity is found for vimentin and CD68, S-100 protein, lysozyme, α1-antitrypsin and antichymotrypsin, indicating histiocytic differentiation.

These tumors are locally aggressive and tend to recur after curettage. Complete surgical excision is the recommended treatment with a good prognosis.

Marginal excision or wide excision is an open debate, Sanatkumar et al. reported a single case of recurrence 17 months after the operation, although the resection margin was 3,0 cm beyond the tumor [6]. Clarke et al. reported three cases of recurrence after tumor curettage among eight operated patients [11]. A case reported by van Giffen et al. had lung metastases [12].

Allografts, non-vascularized and vascularized autografts, and other osteosynthesis procedures have been used with varying degrees of success, and clinical outcomes are variable.

In our patient, to prevent recurrence and preserve optimal limb function, we performed a wide resection with a resection margin of 2.5 cm beyond the tumor and reconstruction with a graft taken from the ipsilateral iliac crest. No recurrence has been found after one year, but long-term follow-up is essential.


Conclusion

Bone BHF is a rare and little-known benign tumor. The diagnosis can be difficult, on the one hand because this tumor presents an atypical clinic and microscopic features which are not pathognomonic. The surgical excision must be complete to avoid recurrence.


References

  1. Zizah S, Benabid M, Bennani A, Ammoumri O, Belkadi K, Marzouki A, et al. Un cas rare d’histiocytofibrome bénin de la cheville. Médecine et chirurgie du pied. 2010 Dec;26(4):113-6.
  2. Sassi SH, Trabelsi M, Abid L, Mrad K, Abbess I, Dhouib R, et al. L’histiocytofibrome bénin profond: à propos d’un cas. Revue de chirurgie orthopédique et réparatrice de l'appareil moteur. 2006 Dec 1;92(8):809-12.
  3. Onovo OD, Eyesan SU, Abdulkareem FB. Benign fibrous histiocytoma of a metacarpal bone. BMJ Case Rep. 2011 Mar 1;2011:bcr0620103122. Pubmed PMID: 22715263.
  4. Lodwick GS. Radiographic diagnosis and grading of bone tumors, with comments on computer evaluation. Proc Natl Cancer Conf. 1964;5:369-80. Pubmed PMID: 5856167.
  5. Grohs JG, Nicolakis M, Kainberger F, Lang S, Kotz R. Benign fibrous histiocytoma of bone: a report of ten cases and review of literature. Wiener Klinische Wochenschrift. 2002 Jan 1;114(1-2):56-63.
  6. Sanatkumar S, Rajagopalan N, Mallikarjunaswamy B, Srinivasalu S, Sudhir NP, Usha K. Benign fibrous histiocytoma of the distal radius with congenital dislocation of the radial head: a case report. J Orthop Surg (Hong Kong). 2005 Apr;13(1):83-7. Pubmed PMID: 15872408.
  7. Ou DM, Zheng GS, Liao GQ, Su YX, Liu HC, Liang YJ. Clinical and pathologic characteristics and surgical management of benign fibrous histiocytoma of the mandible: a case report. J Oral Maxillofac Surg. 2012 Nov;70(11):2719-23. Pubmed PMID: 22580097.
  8. Amghar J, Benhammou M, Lemhaoui A, Aharram S, Daoudi A. osseous histiocytofibroma of the proximal tibia a rare case nd. 6.
  9. Dominok GW, Eisengarten W. Benign fibrous histiocytoma of bone (author's transl). Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie. 1980 Jan 1;124(1-2):77-83.
  10. The World Health Organization’s histologic classification of bone tumors. A commentary on the second edition. 1972:7.
  11. Clarke BE, Xipell JM, Thomas DP. Benign fibrous histiocytoma of bone. The American journal of surgical pathology. 1985 Nov 1;9(11):806-15.
  12. van Giffen NH, van Rhijn LW, van Ooij A, Cornips E, Robben SG, Vermeulen A, et al. Benign fibrous histiocytoma of the posterior arch of C1 in a 6-year-old boy: a case report. Spine (Phila Pa 1976). 2003 Sep 15;28(18):E359-63. Pubmed PMID: 14501936.

         Indexed in

pubhub  CGS  indexcoop  
j-gate  DOAJ  Google_Scholar_logo

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


porn